ArticlemBio2019
Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.
Open access · goldAbstract read
In one paragraph
Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 86 citations in OpenAlex.
- Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.Annals of clinical microbiology and antimicrobials · 2024Pooled it
- Global prevalence and antibiotic resistance in clinical isolates ofFrontiers in medicine · 2023Pooled it
- Risk factors of lower respiratory tract infection caused byFrontiers in public health · 2022Pooled it
- Treatment Patterns and Clinical Outcomes in Children withMicroorganisms · 2026Article
- From nature to clinic: tracking genetic and environmental drivers of Stenotrophomonas maltophilia pathogenicity.Archives of microbiology · 2026Review
- Article
- Deep learning insights into β-lactamase dynamics and resistance evolution.The Biochemical journal · 2026Review
- ComparativeAntimicrobial agents and chemotherapy · 2026Article
- Prevalence ofJournal of clinical microbiology · 2026Article
- Genomic characterization of clinical Stenotrophomonas strains from Thailand reveals five putative novel genospecies and extensive functional diversity.Scientific reports · 2026Article
- Hemodialysis Central Venous Catheter-Associated Bloodstream Infection Caused byAntibiotics (Basel, Switzerland) · 2026Article
- Antibiotic Resistance, Biofilm Genes, and smeDEF Efflux Pump in Clinical Stenotrophomonas maltophilia Isolates From Iran.MicrobiologyOpen · 2026Article
- Genomic phylogeny, taxonomic classification, genetic landscape, and antibiotic resistance of clinicalFrontiers in microbiology · 2026Article
- Antimicrobial resistance mechanisms, treatment challenges, and emerging strategies inFrontiers in cellular and infection microbiology · 2026Review
- Case Report: Dynamic susceptibility-informed therapy for bile leak-associated intra-abdominalFrontiers in medicine · 2026Article
- Diversity Among Clinical and Fresh Produce Isolates ofFoods (Basel, Switzerland) · 2025Article
- Draft genome sequence ofMicrobiology resource announcements · 2025Article
- Ceftazidime retainsmSphere · 2025Article
- Article
- Evidence of dissemination of aAntimicrobial agents and chemotherapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 7 institutions in 3 countries.
Maria F MojicaDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Joseph D RutterResearch Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Magdalena TaracilaResearch Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Luciano A AbriataLaboratory for Biomolecular Modeling, Institute of Bioengineering, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Derrick E FoutsJ Craig Venter Institute, Rockville, Maryland, USA.ORCID 0000-0003-4323-7668
Krisztina M Papp-WallaceDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID 0000-0002-9976-7898
Thomas J WalshTransplantation Oncology Infectious Diseases Program, Weill Cornell Medical Center, New York, New York, USA.
John J LiPumaDepartment of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Alejandro J VilaInstituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario, Argentina.
Robert A BonomoDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA Robert.Bonomo@va.gov.
Louis Stokes Cleveland VA Medical Center · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARCornell University · USGeriatric Research Education and Clinical Center · USJ. Craig Venter Institute · USSIB Swiss Institute of Bioinformatics · CHUniversity of Michigan · US
Funding
The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7MUnderstanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6MUnderstanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9MA Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4MMolecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniaeR21AI114508 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., VAN DUIN, DAVID · 2015 to 2016
$445kThe Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–BLRD VA I01 BX001974NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS R21 AI114508NIAID NIH HHS U19 AI110819
Abstract
PubMed holds no abstract for this paper.
Indexed as
Genetic VariationAnti-Bacterial AgentsAzabicyclo CompoundsAztreonambeta-Lactamase Inhibitorsbeta-LactamasesCeftazidimeDrug CombinationsDrug Resistance, Multiple, BacterialGenotypeGram-Negative Bacterial InfectionsHumansMicrobial Sensitivity TestsMicrobiological TechniquesMolecular EpidemiologyMultilocus Sequence TypingAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsAztreonambeta-Lactamase Inhibitorsbeta-LactamasesCeftazidimeDrug Combinationsantibiotic resistancebeta-lactamasesmolecular epidemiologyStenotrophomonas maltophilia
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.